Literature DB >> 1336803

Increased globotriaosylceramide in familial dysautonomia.

P Strasberg1, H Yeger, I Warren.   

Abstract

Familial Dysautonomia (FD) is an autosomal recessive disease of unknown etiology, occurring primarily in Ashkenazi Jews. Patients are neurologically impaired, with deficits primarily in autonomic and sensory functions. The biochemical and genetic defects have remained elusive, precluding carrier detection and prenatal diagnosis. High-performance liquid chromatography data indicated up to a threefold increase in the neutral glycosphingolipid globotriaosylceramide in Dysautonomic fibroblasts and lymphoblasts. Total ganglioside values, measured by colorimetric, fluorometric or specific sodium borohydride incorporation, were decreased. Affected fibroblasts exhibited a range of pleomorphic phenotypes, such that the usual swirl-like confluent growth pattern of normal fibroblasts was distorted to varying degrees, suggesting abnormalities in the FD plasma membrane, possibly affecting cell-cell contacts. The glycosphingolipid increase could not be accounted for on the basis of markedly decreased alpha-galactosidase activity, as in Fabry's disease, where patients also display decreased autonomic function.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1336803     DOI: 10.1007/bf02535575

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  38 in total

1.  Incidence of familial dysautonomia in Israel 1977-1981.

Authors:  C Maayan; E Kaplan; S Shachar; O Peleg; S Godfrey
Journal:  Clin Genet       Date:  1987-08       Impact factor: 4.438

2.  Glycosphingolipids in cultured human skin fibroblasts. I. Characterization and metabolism in normal fibroblasts.

Authors:  G Dawson; R Matalon; A Dorfman
Journal:  J Biol Chem       Date:  1972-09-25       Impact factor: 5.157

3.  Two types of ribosome in mouse-hamster hybrid cells.

Authors:  C P Stanners; G L Eliceiri; H Green
Journal:  Nat New Biol       Date:  1971-03-10

Review 4.  Gangliosides: structure, isolation, and analysis.

Authors:  R W Ledeen; R K Yu
Journal:  Methods Enzymol       Date:  1982       Impact factor: 1.600

5.  Ganglioside GM3 can induce megakaryocytoid differentiation of human leukemia cell line K562 cells.

Authors:  M Nakamura; K Kirito; J Yamanoi; T Wainai; H Nojiri; M Saito
Journal:  Cancer Res       Date:  1991-04-01       Impact factor: 12.701

6.  Derivatives of ganglioside GM1 as neuronotrophic agents: comparison of in vivo and in vitro effects.

Authors:  M S Cannella; B Oderfeld-Nowak; M Gradkowska; M Skup; L Garofalo; A C Cuello; R W Ledeen
Journal:  Brain Res       Date:  1990-04-16       Impact factor: 3.252

7.  Verotoxin-resistant cell clones are deficient in the glycolipid globotriosylceramide: differential basis of phenotype.

Authors:  A Pudymaitis; G Armstrong; C A Lingwood
Journal:  Arch Biochem Biophys       Date:  1991-05-01       Impact factor: 4.013

8.  Neuraminic acid-specific modification and tritium labelling of gangliosides.

Authors:  R Veh; A P Corfield; M Sander; R Schauer
Journal:  Biochim Biophys Acta       Date:  1976-01-18

9.  Structural gene for beta-nerve growth factor not defective in familial dysautonomia.

Authors:  X O Breakefield; G Orloff; C Castiglione; L Coussens; F B Axelrod; A Ullrich
Journal:  Proc Natl Acad Sci U S A       Date:  1984-07       Impact factor: 11.205

10.  Type 2 GM1 gangliosidosis with long survival and neuronal ceroid lipofuscinosis.

Authors:  J A Lowden; J W Callahan; R A Gravel; M A Skomorowski; L Becker; J Groves
Journal:  Neurology       Date:  1981-06       Impact factor: 9.910

View more
  4 in total

1.  Establishment of a monoclonal antibody directed against Gb3Cer/CD77: a useful immunochemical reagent for a differentiation marker in Burkitt's lymphoma and germinal centre B cells.

Authors:  D Miyamoto; T Ueno; S Takashima; K Ohta; T Miyawaki; T Suzuki; Y Suzuki
Journal:  Glycoconj J       Date:  1997-04       Impact factor: 2.916

2.  Decreased incorporation of D-glucosamine into glycosphingolipids of intact Familial Dysautonomia lymphoblasts.

Authors:  P M Strasberg; A Novak; I B Warren
Journal:  J Mol Neurosci       Date:  1995       Impact factor: 3.444

3.  Increased globotriaosylceramide on plasma membranes of synchronized familial dysautonomia cells. Verotoxin binding studies.

Authors:  J Pereira; B Boyd; J Newbigging; C Lingwood; P M Strasberg
Journal:  J Mol Neurosci       Date:  1994       Impact factor: 3.444

4.  Alpha 1,4galactosyltransferase activity and Gb3Cer expression in human leukaemia/lymphoma cell lines.

Authors:  C L Stults; R D Larsen; B A Macher
Journal:  Glycoconj J       Date:  1995-10       Impact factor: 2.916

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.